Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stage – MarketWatch

At least two experimental COVID-19 vaccines produced a T-cell reaction in participants in early-stage medical trials, which may indicate a more long lasting kind of resistance than an antibody response. Bi … [+3274 chars]